• 1
    Geerts WH, Heit JA, Clagett GP et al. Prevention of venous thromboembolism. Prevention of venous thromboembolism: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 338S400.
  • 2
    Consensus Report. Prevention of venous thromboembolism: international consensus statement (guidelines according to scientific evidence). Int Angiol 1997; 16: 338.
  • 3
    Sandercock PAG, van den Belt AGM, Lindley RI, Slattery J. Antithrombotic therapy in acute ischaemic stroke: an overview of de completed randomised trials. J Neurol Neurosurg Psychiatry 199; 56: 1725.
  • 4
    Belch JJ, Lowe GDO, Ward AG, Forbes CD, Prentice CR. Prevention of deep vein thrombosis in medical patients by low-dose heparin. Scott Med J 1981; 36: 1157.
  • 5
    Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982; 10: 44850.
  • 6
    Halkin H, Goldberg J, Modan M, Modan B. Reduction of mortality in general medical in-patients by low-dose heparin prophylaxis. Ann Intern Med 1982; 348: 2056.
  • 7
    Dahan R, Houlbert D, Caulin C et al. Prevention of deep vein thrombosis in elderly medical in-patients by a low molecular weight heparin: a randomized double-bind trial. Haemostasis 1986; 16: 15964.
  • 8
    Ibarra-Pérez C, Lau-Cortes E, Colmenero-Zubiate S et al. Prevalence and prevention of deep venous thrombosis of the lower extremities in high-risk pulmonary patients. Angiology 1988; 39: 50513.
  • 9
    Bergmann JF, Caulin C. Heparin prophylaxis in bedridden patients. Lancet 1996; 348: 2056.
  • 10
    Gärdlund B. Randomised, controlled trial of low-dose heparin for prevention of fatal pulmonary embolism in patient with infectious disease. Lancet 1996; 347: 135761.
  • 11
    Samama MM, Cohen AT, Darmon JY et al. A comparison of enoxaparin with placebo for the prevention of venous thromboembolism in acutely ill medical patients. Prophylaxis in medical patients with Enoxaparin Study Group. N Engl J Med 1999; 341: 793800.
  • 12
    Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A, Patwardhan NA. Physician practices in the prevention of venous thromboembolism. Ann Intern Med 1991; 115: 5915.
  • 13
    Aujesky D, Guignard E, Pannatier A, Cornuz J. Pharmacological thromboembolic prophylaxis in a medical ward. J Gen Intern Med 2002; 17: 78891.
  • 14
    Chmelik P, Chopard P, Bounameaux H. An evaluation of thromboembolism prophylaxis in acutely ill medical patients. Swiss Med Wkly 2002; 132: 5136.
  • 15
    Rahim SA, Panju A, Pai M, Ginsberg J. Venous thromboembolism prophylaxis in medical inpatients: a retrospective chart review. Thromb Res 2003; 111: 2159.
  • 16
    Fiessinger JN, Chatelier G. Effect of prescription and monitoring recommendations on prescription of low-molecular weight heparins. Presse Med 1996; 25: 177780.
  • 17
    Durieux P, Nizard R, Ravaud P et al. A clinical decision support system for prevention of venous thromboembolism: effect on physician behavior. JAMA 2000; 283: 281621.
  • 18
    Alikhan R, Cohen AT, Combe S et al. Risk factors for venous thromboembolism in hospitalised patients with acute medical illness: analysis of the MEDENOX study. Arch Intern Med 2004; 164: 9638.